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Abstract
Background
LKB1 is an evolutionary conserved kinase implicated in a wide range of cellular functions
including inhibition of cell proliferation, regulation of cell polarity and metabolism. When
Lkb1 is inactivated in the liver, glucose homeostasis is perturbed, cellular polarity is affected
and cholestasis develops. Cholestasis occurs as a result from deficient bile duct develop-
ment, yet how LKB1 impacts on biliary morphogenesis is unknown.
Methodology/Principal Findings
We characterized the phenotype of mice in which deletion of the Lkb1 gene has been spe-
cifically targeted to the hepatoblasts. Our results confirmed that lack of LKB1 in the liver
results in bile duct paucity leading to cholestasis. Immunostaining analysis at a prenatal
stage showed that LKB1 is not required for differentiation of hepatoblasts to cholangiocyte
precursors but promotes maturation of the primitive ductal structures to mature bile ducts.
This phenotype is similar to that obtained upon inactivation of Notch signaling in the liver.
We tested the hypothesis of a functional overlap between the LKB1 and Notch pathways by
gene expression profiling of livers deficient in Lkb1 or in the Notch mediator RbpJκ and iden-
tified a mutual cross-talk between LKB1 and Notch signaling. In vitro experiments confirmed
that Notch activity was deficient upon LKB1 loss.
Conclusion
LKB1 and Notch share a common genetic program in the liver, and regulate bile duct
morphogenesis.
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Introduction
The liver is a vital organ with many functions, one of which is bile production for lipid adsorption
[1]. Bile ducts lined by cholangiocytes carry bile produced by the hepatocytes to the intestinal
tract. During liver development, hepatoblasts differentiate into hepatocyte and cholangiocyte pre-
cursors which progressively mature to adult hepatocytes organized as cords and to cholangiocytes
organized as ducts. Cholangiocyte precursors initially surround the portal vein mesenchyme, and
form a ductal plate. The latter subsequently undergoes morphogenesis and remodelling to gener-
ate the bile ducts [2–4]. Defects in bile duct formation can impair bile duct flow eventually leading
to cholestasis.
Human genetic diseases and mutant mouse models have illustrated the importance of
Notch signaling in the development of bile ducts [5]. Alagille syndrome is an inherited disorder
characterized by bile duct paucity and variable degree of cholestasis [6]. Nearly 80% of patients
have mutations in JAGGED1 which encodes for a Notch receptor ligand; less frequently the
gene encoding for the Notch receptor NOTCH2 is mutated [7–9]. Upon ligand binding the
Notch receptor undergoes sequential proteolysis releasing the intracellular domain (NICD)
that translocates to the nucleus and associates with RbpJκ (Recombination signal binding pro-
tein immunoglobulin J kappa) to convert the RbpJκ corepressor complex into a coactivator
complex that stimulates gene transcription [5]. Mouse studies showed that Notch signaling
controls differentiation of bipotential hepatoblasts towards cholangiocytes as well as bile duct
morphogenesis [10–17].
LKB1 is a tumor suppressor encoded by the STK11 gene. It is an evolutionary conserved ser-
ine/threonine protein kinase implicated in a wide range of cellular functions including inhibi-
tion of cellular proliferation, regulation of cellular polarity and metabolism [18–20]. It is a
multi-task kinase that acts upstream of AMPK (AMP-activated protein kinase) and 12 AMPK-
related kinases [21]. LKB1 is a crucial regulator of apical epithelial cell polarity [19], and is able
to polarize intestinal epithelial cells [19,22,23]. However, this effect of LKB1 may be cell-type
specific, as deletion of LKB1 does not alter polarity of lung epithelial and pancreatic cells [24].
In the adult liver, LKB1 controls glucose and lipid metabolism [20,25,26]. In vitro studies
showed that LKB1 is required for hepatocyte polarization and establishment of the canalicular
network [27]. Bile duct paucity was observed in mice bearing a deletion of LKB1 in the liver
[28]. However, a developmental cause for the biliary defect was not investigated.
Here, we characterized the phenotype of mice in which the LKB1 gene has been specifically
deleted in the hepatoblasts. Mutant mice were strongly cholestatic and lacked bile ducts. Stud-
ies at the prenatal stage showed that LKB1 is not required for differentiation of cholangiocyte
progenitors and for ductal plate formation, but is required for bile duct morphogenesis by pro-
moting the maturation of the primitive ductal structures. At the molecular level, we showed
that LKB1 and Notch share a common genetic program in the liver, identifying a cross-talk
between LKB1 and Notch that likely regulates biliary morphogenesis.
Materials and Methods
Animals
Mice carrying two floxed alleles on the exons III to VI of the Lkb1 gene (Stk11lox/lox) [29] were
interbred with AlfP-Cre in which Cre is under the control of Albumin regulatory elements and α-
feto-protein enhancer [30] to generate mice with LKB1 deletion in the hepatoblasts (LKB1livemb).
Inactivation of the Notch pathway was carried out by crossing AlfP-Cre animals with mice carry-
ing floxed allele of RbpJκ [31], an essential co-factor of NICD. All animal procedures were carried
out according to French legal regulations and approved by an ethical committee, “Comité
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National de Réflexion Ethique sur l’Expérimenation Animale” under the registered number:
CEEA34.CP.077.12. All mice were kept in well-controlled animal housing facilities.
RNA extraction and RT-PCR
Total RNA was extracted from mouse tissues and cell lines with Trizol Reagent (Life technolo-
gies) according to manufacturer’s protocol. Reverse transcription was performed from 1 μg of
total RNA using Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics) and ran-
dom hexamer as primers. Quantitative PCR reactions were run using the Light Cycler 480 Sybr
Green I Master kit (Roche) and specific primers (Eurogentec) on a Light Cycler 480 thermocy-
cler (Roche). Values were normalized with 18S ribosomal RNA. Primer sequences are indicated
in S1 Table.
Immunoblot analysis
Total protein extracts from mouse liver were obtained from 100–200 mg of frozen tissue that
was bead-mill homogeneized in lysis buffer (50 mM Tris-HCl pH 7.4, 150 mMNaCl, 1 mM
EGTA, 1 mMDTT, 0.1 mM AEBSF, 1% Triton X-100), supplemented with a mixture of prote-
ase and phosphatase inhibitors (Roche) in a 10μl/μg ratio using a TissueLyser disruption sys-
tem (Qiagen, Hilder, Germany). Samples were centrifuged at 13.000 g for 10 min at 4°C and
supernatant was collected and kept at -80°C until analysis. Proteins were resolved by SDS–
PAGE, transferred to nitrocellulose and blocked with 5% BSA or 5% milk. Blots were incubated
with specific primary antibodies overnight at 4°C, washed, incubated with the corresponding
horseradish peroxidase-conjugated secondary antibodies (Cell Signaling) and developed by
enhanced chemiluminescence (Thermo Fisher Scientific, Waltham, MA). Images were
recorded using a super CCD camera of 3.2 megapixels driven by the LAS 4000 mini device (GE
Healthcare). LKB1 antibody (clone D60C5), AMPK and anti-phospho-AMPKαT172 were
from Cell Signaling Technologies. β-actin antibody was from Sigma Aldrich.
Blood biochemistry
Bilirubin levels were measured from plasma using the Bilirubin SF kits from Diasys according
to the manufacturer instructions. ALAT levels were measured from plasma using the ALATSF
kit from Diasys and according to the manufacturer instructions
Immunohistochemistry and Immunofluorescence
Mouse liver were minced in 3mm-thick sections and fixed in 10% formalin for 12 hours and
embedded in paraffin. For morphological analysis, dewaxed 2μm sections were stained with
hemalun and eosin.
CK19 and CD10 immunostaining procedures were performed on 5μm thick dewaxed tissue
section, boiled in pH6 citrate buffer for 40 minutes and incubated for 1h at room temperature
with primary antibody. After incubation with biotinylated secondary antibody, an avidin-bio-
tin amplification step was performed (Jackson laboratories) followed by a diaminobenzidine-
based revelation (Jackson laboratories) and counterstaining in hemalun. Anti-CD10 immuno-
histochemistry was performed using the MOM kit (Vector Laboratories). Anti-CK19 was a gift
from Sylvie Germain and anti-CD10 was from Tebu-Novocastra. Immunofluorescence stain-
ing for aPKCz was done on frozen sections. Antibody anti- aPKCz was from Santa-Cruz.
For immunostaining of developing bile ducts, embryos were fixed at 4°C for 4h in 4% para-
formaldehyde in PBS, washed overnight in PBS and embedded in paraffin. Tissue sections
were retrieved by boiling for 10 min in pH6 citrate buffer, permeabilized for 15 minutes with
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0.3% Triton X-100-PBS, and blocked in 3% milk/10% BSA/0.3% Triton X-100 in PBS for 45
minutes at room temperature. Primary antibodies were purchased from Santa-Cruz (HNF4,
HNF6 and HNF1β), BD biosciences (E-cadherin), Chemicon (Sox9), R&D systems (osteopon-
tin). Anti-HES1 was provided by B. Stanger, and anti-Notch2 NICD developed by S. Artava-
nis-Tsakonas was obtained from the Developmental Study Hybridoma Bank, created by the
NICHD of the NIH and maintained at the University of Iowa, Department of Biology, Iowa
City, IA 52242. Incubation of primary antibodies was performed in 3% milk/10% BSA/0.3%
Triton X-100 in PBS for 1 hour at 37°C. Washes were done with 0.1% Triton X-100 in PBS
three times for 5 minutes each. Secondary antibodies Alexa Fluor1 conjugated were purchased
from LifeTechnologies. Washes were repeated with 0.1% Triton X-100-PBS three times for 5
minutes each and slides were mounted in Dako1 fluorescent mounting medium (Dako). Fluo-
rescence was immediately observed with a Zeiss Axiovert 200 inverted fluorescence micro-
scope. All the pictures were taken using a Coolpix 995 digital camera (Nikon).
Microarray analysis, statistical analysis and data mining
Three hundred ng of total RNA were reverse transcribed following the Genechip Whole tran-
script (WT) Sense Target labelling assay kit (Affymetrix). The resulting cDNA was used for in
vitro transcription with T7 RNA polymerase. After purification, 10 μg of cRNA was used for
reverse transcription with random primers. The cDNA obtained was purified and fragmented.
After control of fragmentation using 2100 Bioanalyzer, cDNA was end-labelled with biotin
using Terminal Transferase (WT terminal labelling kit, Affymetrix). cDNA was then hybrid-
ized to GeneChip1Mouse Gene (Affymetrix) at 45°C for 17 hours. Chips were washed on
the fluidic station FS450 following specific protocols (Affymetrix) and scanned using the
GCS3000 7G. The image was analyzed with Expression Console software (Affymetrix) to
obtain raw data (cel files) and metrics for Quality Controls. Data have been deposited in GEO
database (GSE75564).
Microarray data were analyzed using R-based BRB-Array Tools as previously described
[32]. Briefly, differentially expressed genes were identified by a univariate two-sample t-test
with a random variance model. Individual genes were selected on the basis of both statistical
significance (p<0.001) and fold change (FC) difference between the compared groups
(FC>1.5). False discovery rate (FDR)/q-value has been calculated as previously described [33].
Ingenuity pathway analysis (IPA) software (Mountain View, CA, USA) was used to examine
the functional association between differentially expressed genes and to generate the most sig-
nificantly altered molecular functions that were identified using the scoring system provided
by IPA. Gene set enrichment analysis (GSEA) was performed by using the Java-tool developed
at the Broad Institute (Cambridge, MA, USA).
Cell Culture and Transfections
The human cholangiocarcinoma Mz-ChA-1 [34], a gift of Laura Fouassier (Inserm UPMC
UMRS-938, Paris France) and the human hepatocellular carcinoma cell line HUH7 were culti-
vated in Dubelcco’s modified Eagle’s medium (DMEM, Life Technologies) supplemented with
10% fetal bovine serum and 100U/ml penicillin/streptomycin at 37°C under 5% CO2. For
transfection, 0.5x106 cells were seeded in each well of a 6-well plate. The Notch RBPJ reporter
plasmid contains four copies of the RbpJκ-binding element cloned upstream of a SV40 pro-
moter-driven luciferase reporter construct and was a kindly gift from Evelyne Lauret (Institut
Cochin, Paris, France). The expression vector encoding Notch 1 intracellular domain (NICD)
was a gift from Evelyne Lauret (Institut Cochin, Paris, France). The human LKB1 siRNA pool
is a SMART selection designed from Thermo Fischer Scientific, Dharmacon Product. Human
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scrambled siRNA (ON-TARGETplus-Non-Targeting pool) was from Dharmacon. RSV-Re-
nilla was used to normalize transfection efficiency. Cells were either co-transfected with
increasing doses of NICD, 250 ng of RBPJ reporter and 10 ng of RSV-Renilla, or co-transfected
with 50 or 100 pmol of siRNA, 250 ng of RBPJ reporter and 10 ng of RSV-Renilla. The transfec-
tion was done using the Lipofectamine1 RNAiMAX protocol according to the manufacturer’s
protocol (Life Technologies). Forty-eight hours after transfection, Luciferase activity was mea-
sured with the Dual-Luciferase reporter assay system (Promega, Madison, WI). Results were
expressed as firefly luciferase activity normalized to Renilla luciferase activity of the same sam-
ple. Each point was done in triplicate.
Results
Liver cholestasis is induced in mice with LKB1 deletion in hepatoblasts
We specifically deleted Lkb1 in the liver using mice with floxed Lkb1lox/lox alleles [29] and
transgenic Alfp-Cre [30]. In the latter, Cre recombinase is active in hepatoblasts starting at
E10.5. The mutant animals were named LKBKOLivemb. After confirming that Lkb1 was effi-
ciently deleted in the liver (Fig 1A), we studied the phenotype of these mice. LKBKOLivemb
mice were born at the expected Mendelian frequency, but showed severe growth retardation
beginning at post-natal day 12 and leading to death between day 25 and day 30 (Fig 1B and
1C). The severity of the phenotype of LKBKOLivemb mice differed from that observed in the
work by Woods et al. [28]. In the latter, defective growth was detected at an earlier stage (post-
natal day 4) while we observed growth defect at the suckling/weaning transition. Furthermore,
Woods et al. detected cytolysis as assessed by elevated transaminase levels; in contrast, we
found normal serum ALAT levels in LKBKOLivemb mice. The difference in the liver phenotype
between the two studies is likely explained by the genetic difference of the two models: Woods’
study was done using an hypomorphic floxed Lkb1 model harbouring strong reduction in
LKB1 protein expression in Cre-negative mice [35] while no such decrease was observed in our
Cre-negative mice (Fig 1A).
The LKBKOLivemb mice were strongly cholestatic as shown by the yellow color of the serum
and elevated serum bilirubin levels (Fig 1D). The high level of conjugated bilirubin and the
normal ALAT levels indicated that cholestasis resulted from a biliary obstruction (Fig 1D). Bile
canaliculi are channels formed by the juxtaposition of apical pole of adjacent hepatocytes.
Using the apical marker aPKCz to detect the bile canaliculi, we found, as expected, an elon-
gated and bar-shaped bile canalicular network in control animals. In contrast, the aPKCz stain-
ing was tortuous and dilated in LKBKOLivemb mice (Fig 2A). Mutant mice failed to express the
hepatocyte canalicular membrane, CD10 [36], reinforcing that bile canalicular network was
defective (Fig 2A). Similar results were observed in the Wood’s study [28]. We then examined
the intrahepatic bile ducts in LKBKOLivemb mice. In control livers at postnatal day 15, one to
two CK19-positive bile ducts were located in each portal tract (Fig 2B). In contrast, mutant ani-
mals showed CK19-positive cells organized around the portal tract like embryonic ductal plate
structures, but failed to develop ducts (Fig 2B). Thus, LKBKOLivemb mice revealed defects in
hepatocytes with aberrant apical polarization leading to defective bile canaliculi, and defects in
bile duct formation that all were responsible for the cholestasis.
LKB1 promotes maturation of bile ducts during biliary morphogenesis
To determine how LKB1 deletion causes defective duct formation, we analyzed bile duct mor-
phogenesis at prenatal stages. During normal embryonic development, hepatic progenitor cells
adjacent to the portal vein form a structure composed of cholangiocyte precursors, called duc-
tal plate. Then, prior to birth, tubulogenesis occurs at discrete areas along the ductal plate,
LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis
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Fig 1. Phenotype of mice carrying Lkb1 deletion in the embryonic liver. (A) LKBKOlivemb mouse model results in efficient inactivation of Lkb1 protein
expression in the liver. Western blot analysis of Lkb1 and β-actin (loading control) of liver lysates from wild-type, control (LKB1fl,fl, Cre-) designedWT and
mutant (LKB1fl,fl, Cre+) mice designed KO (2-week old mice). (B) Gross appearance of a control (WT) and mutant (KO) LKBKOlivemb mice at postnatal day
28. (C)Weight curves from birth to post-natal day 30 in the LKBKOlivemb model. Mice genotypes were determined at postnatal day 5. N = 15 control and 8
mutant mice. Error bars: standard deviations.* P<0.01, ** P<0.05, *** P<0.001. Deletion of Lkb1 in the embryonic liver causes postnatal growth retardation
beginning at day 12. (D)Obstructive cholestasis in LKBKOlivemb mutant mice. Gross aspect of serum from a control (WT) and mutant (KO) LKBKOlivemb mice
at postnatal day 15. Blood levels of conjugated bilirubin and ALAT in LKBKOlivemb control (WT) and mutant (KO) mice at postnatal day 15. n = 6 control and 4
mutant mice. Error bars: standard deviations. Statistical significance was evaluated using a two-sample unpaired Student’s t-test between KO and mutant
animals. *** P<0.001.
doi:10.1371/journal.pone.0145400.g001
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Fig 2. Lkb1 is required for canaliculi formation and intrahepatic bile ducts morphogenesis. (A) Top
panel: representative images of 3-week old control and mutant LKBKOlivemb mice liver sections stained with
the apical marker aPKCζ. Note the elongated canalicular network and the tortuous dilated bile canaliculi in
control and mutant animal, respectively. Bottom panel: representative images of 3-week old control and
mutant LKBKOlivemb mice liver sections stained with the anti-CD10 antibody. Immunohistochemistry
LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis
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giving rise to asymmetrical ducts, called primitive ductal structures (PDS) lined by Sox9
+/HNF4- cholangiocytes and Sox9-/HNF4+ hepatoblast-like cells. Around embryonic day
E17-E18, these structures mature to bile ducts entirely and symmetrically lined by Sox9
+/HNF4- cholangiocytes [3,37]. Cholangiocyte precursors of the ductal plate not involved in
duct formation give rise to periportal hepatocytes and to cells of the Hering’s canal [38].
In control animals, at E18.5, developing ducts were symmetrical and completely lined with
Sox9+/HNF4- cells. In contrast, at that stage developing ducts of LKBKOLivemb mice were still
in an asymmetrical configuration typical of PDS: the duct lumina were surrounded on the por-
tal side by Sox9+/HNF4- cholangiocytes and on the opposite, i.e. parenchymal side, by Sox9-/
HNF4+ hepatoblasts (Fig 3A). We then tested the expression of key transcription factors of
bile duct morphogenesis, namely HNF1β and HNF6 [39–41]. These factors were normally
expressed on the parenchymal and portal sides of developing ducts, in wild-type livers and
only in the portal side of the ducts of the LKBKOLivemb livers (Fig 3B). As well, the nuclear loca-
tion of the Notch intracellular domain (NICD) and the expression of the Notch target gene
Hes1 were asymmetrical in developing ducts of mutant embryos, in contrast to control animals
revealing a symmetrical expression (Fig 3C). These data demonstrated that in the absence of
LKB1, duct morphogenesis is arrested at the PDS stage and that Notch signaling is not func-
tional on the parenchymal side of the developing ducts in the absence of LKB1. In mutant
animals, the PDS do not mature to bile ducts and, together with the other cholangiocyte pre-
cursors not involved in duct formation, remain at an embryonic stage, explaining the ductal-
plate-like structure observed in adult animals.
Cross-talk between LKB1 and Notch pathways in liver
The biliary phenotype of LKBKOLivemb mice is reminiscent of that observed in mice with inac-
tivation of Hes1, Jagged 1, or RbpJκ [11,15,17]: all these mice develop a ductal plate which fails
to generate ducts. This suggested that LKB1 cross-talks with the Notch pathway in the liver. To
check this hypothesis we analyzed Rbpjlox/lox;Alfp-Cre (RBPJKOlivemb) mice which have a liver-
specific inactivation of RbpJκ. Control, RBPJKOlivemb and LKBKOLivemb mice were sacrificed 5
days after birth and the liver transcriptomes were analyzed using microarrays. 253 non redun-
dant genes were differentially expressed between LKBKOLivemb and control mice (see S2
Table); 237 genes were differentially expressed between RBPJKOlivemb and control mice (see S3
Table). Interestingly, numerous genes (54 out of 55 genes, i.e. 20–25% of each list, see S4 Table)
were similarly deregulated in the liver of LKBKOLivemb and RBPJKOlivemb mice (Fig 4A).
Accordingly, Gene Set Enrichement Analysis (GSEA) revealed that the LKBKOlivemb gene sig-
nature was significantly enriched in the gene expression profile of RBPJKOlivemb livers, and
vice versa (Fig 4B). Analysis of functional gene networks using Ingenuity Pathway Analysis
highlighted the metabolic pathways as the main deregulated pathways in both the LKB1 and
Notch gene datasets (Fig 4C).
To confirm in vitro, the cross-talk between LKB1 and Notch signaling pathways the cholan-
giocarcinoma cell line Mz-ChA-I was used. A Notch-responsive luciferase reporter system
containing RbpJκ binding sites [42] allowed us to monitor the level of Notch activation.
evidences a delicate canalicular network at the apical pole of the hepatocytes of control animal. In KOmice,
the staining was lost. Top: low magnification, middle and bottom: high magnification. (B) Top panel:
Hematoxylin-eosin (H&E) stained sections of 3-week old control and mutant LKBKOlivemb mouse liver. Middle
and bottom panels: Cytokeratin 19 (CK19)-stained sections of 3-week old control and mutant LKBKOlivemb
mouse livers. Note the well-formed and mature bile ducts in the control mouse and the numerous ductal
plate-like structures around the portal tract in mutant mice. Top two panels: high magnification, bottom panel:
scanning magnification.
doi:10.1371/journal.pone.0145400.g002
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Fig 3. Lkb1 controls the maturation of bile duct during bile duct tubulogenesis. (A)
Immunofluorescence for Sox9, HNF4 and E-cadherin demonstrate that Lkb1 is required for the transition
from an asymmetric primitive duct to a symmetric and mature bile duct in the developing liver. LKBKOlivemb
(KO) embryos were sampled at E18.5 and liver sections were stained for the hepatoblast marker HNF4, and
for the cholangiocyte markers Sox9. Note the symmetrical localization of Sox9 around the bile duct in control
mice (Control) whereas Sox9 was only expressed in the portal layer of the asymmetric bile ducts in mutant
embryos. High E-cadherin levels mark mature cholangiocytes. (B) Representative immunofluorescence for
HNF1β and HNF6 in control and LKBKOlivemb livers in top and bottom panels respectively. Medium-high
magnifications. (C) Notch-ICD and Hes-1 expression are restricted to the portal layer of asymmetrical bile
duct in LKBKOlivemb mutant mice whereas Notch activation was evidenced in both layers of the biliary tubules
in control animals. Mediummagnification.
doi:10.1371/journal.pone.0145400.g003
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Fig 4. Inactivation of Lkb1 and Notch in the liver share a common gene signature. (A) RBPJKOlivemb and LKBKOlivemb models share a common gene
expression signature. Upper part: Venn diagram of genes differentially expressed (p<0.001, fold change>1.5) between mutant and control mice in the
LKBKOlivemb and RBPJKOlivemb (5-days old) models. Fifty-five genes were found to be deregulated in the two models. Lower part: Supervised hierarchical
clustering analysis demonstrates that 54 (out of 55) common genes are similarly deregulated in the two models. (B) Gene Set Enrichment Analysis (GSEA)
demonstrates that the Lkb1 and Notch pathways share a common transcriptional program. RBPJKOlivemb (upper part) and LKBKOlivemb (lower part) gene
LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis
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Transfection of NICD induced a dose-dependent increase in luciferase activity, as expected
(Fig 5A). More interestingly, we observed a decrease in luciferase activity after LKB1 inactiva-
tion by siRNA and not in cells transfected with a scrambled siRNA (Fig 5B and 5C). This result
confirmed that Notch activation is deficient in the absence of LKB1. Similar results were
obtained using the hepatocellular carcinoma cell line HUH7 (Fig 5D), indicating that the dialog
between LKB1 and Notch signaling extends beyond bile duct cells. We then search for an epi-
static relation between the LKB1 and Notch signaling, and characterized the activation status
of the Notch pathway in LKB1 mutant animals, and reciprocally, the level of LKB1 expression
in Notch mutant livers. Expression of several Notch pathway targets (Hes1,Hey1,Heyl and
Nrarp) was downregulated in the liver of LKBKOLivemb mutant mice corroborating the results
we obtained using the Mz-ChA-I cell line (Fig 5E). Reciprocally, Notch inactivation was associ-
ated with down-regulation of LKB1 protein and its downstream kinase, AMPK, as revealed by
the level of phosphorylated AMPK (Fig 5F). These results showed a mutual cross-regulation
between the LKB1 and Notch pathways without evidence that one is epistatic to the other.
Discussion
In the present work we identify a new role of LKB1 in bile duct development. In the absence
of LKB1 differentiation of hepatoblasts to cholangiocyte precusors proceeds normally; the
precursors organize as a ductal plate and generate PDS, but the latter fail to mature to ducts. A
similar maturation defect has been observed in the absence of HNF1β [41]. We showed that
Notch pathway activation was deficient in the absence of LKB1, by in vivo and in vitro
approaches. Since Notch pathway deficiencies are associated with a biliary phenotype similar
to that of LKBKOLivemb mice, we suggest that LKB1 controls Notch signaling during bile duct
development.
The failure of PDS to mature and generate ducts may reflect polarity defects in
LKBKOLivemb mice. When PDS mature to ducts, the cells on the parenchymal side become
progressively more polarized and expressed higher level of E-cadherin [37]. A co-localization
between LKB1 and E-cadherin has been described at the adherens junction and E-cadherin is
required for the recruitment of active LKB1 complex to adherens junction in polarized epithe-
lial cells [43]. Thus, a polarity clue mediated by LKB1 may be the signal that allows the transi-
tion of PDS to a symmetric bile duct. In addition, deficient apical polarization of hepatocytes
was likely to explain the abnormal development of bile canaliculi in mutant mice. Therefore,
polarization of hepatocytes and cholangiocytes may constitute a key function of LKB1 during
liver development.
Hepatocytes have a marked anatomical polarity that plays an essential role for biliary secre-
tion. Several bile acid transporters are localized at the canalicular apical pole. In vitro studies
showed that formation and maintenance of bile canalicular network of the hepatocytes is regu-
lated by the LKB1 and AMPK pathways [27]. Accordingly, we observed loss of the bile canalic-
ular network in LKBKOLivemb mice. Thus alterations in both hepatocytes and cholangiocytes
signatures were used for GSEA using the gene expression profiles of LKBKOlivemb (upper part) and RBPJKOlivemb (lower part) mice and their respective
control (WT) counterparts. Up- and down-regulated genes in the RBPJKOlivemb signature were found to be specifically enriched in the gene expression
profiles of LKBKOlivemb and control (WT) mice, respectively. Similarly, up- and down-regulated genes in the LKBKOlivemb signature were found to be
specifically enriched in the gene expression profiles of RBPJKOlivemb and control (WT) mice, respectively. All gene sets were significantly enriched at
nominal p-value<1%. (C) Most significantly altered functions revealed by Ingenuity Pathway Analysis (IPA). A dataset containing gene identifiers and
corresponding values were uploaded to the Ingeniuty Pathway analysis software (IPA). The transcripts differentially expressed between KO andWT that met
the cutoff criteria (FC > 1.5, p< 0.001) were considered for the analysis. Bars represent the logarithmic value of the significance level, the dashed line
corresponds to the threshold of 0.05.
doi:10.1371/journal.pone.0145400.g004
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Fig 5. Cross-talk between LKB1 and Notch signaling. (A) The RBP-J luciferase reporter was transfected into Mz-Cha-1 cells either alone (0) or with
increasing dose of NICD vector (ng) as indicated. (B) Silencing by 50 pmol -100 pmol of LKB1 siRNA (LKB) and scrambled siRNA (SC). LKB1 protein was
revealed by western blot. β-actin was used as loading control. (C-D) LKB1 silencing led to decrease Notch activity. Luciferase activity was measured in the
absence of siRNA (1), in the presence of either 50 pmol of LKB1 siRNA or scrambled siRNA (2) and the presence of 100 pmol of either LKB1 siRNA or
scrambled siRNA (3). Transfections were done in Mz-ChA-1 cells (C) or in HUH7 cells (D). * P< 0.05. ** P<0.01. (E) LKB1 is required for full activation of
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explain the cholestatic phenotype of mutant mice which do not have mature bile ducts and
present defective bile canalicular network.
At the molecular level, our in vivo and in vitro analyses showed that LKB1 loss led to a
decrease in Notch activity, but the mechanism by which LKB1 controls Notch activation
remains to be investigated. Interestingly, our results indicated that Notch-deficient mice dis-
played a decrease in the LKB1 activity highlighting a cross-regulation of LKB1 and Notch sig-
naling. The liver is not the only organ in which LKB1 and Notch cross-talks. A connection
between the LKB1 and Notch pathway has been recently described in the intestinal epithelium.
Deletion of LKB1 in the epithelial cells of the intestine is associated with a modification of the
differentiation of the intestinal lineage towards an increase in goblet and Paneth cell lineage
known to be negatively controlled by Notch signaling [44]. Similar to our results, a decrease in
Notch activation was evidenced in intestine of mice bearing specific deletion of LKB1 [45].
Therefore, our work and that of others point toward a combinatorial role of LKB1 and Notch
in cell fate decision and organ morphogenesis.
Our gene expression profiling results further highlight that the Notch pathway has roles that
extend beyond development and that it impacts on organ homeostasis [5]. Recent data show
that Notch participates in liver glucose and lipid homeostasis [46,47]. Accordingly numerous
genes linked to lipid metabolism were present in the shared LKB1-Notch dataset (see Fig 4A).
Conclusion
Liver-specific deletion of LKB1 in transgenic mice identified LKB1 as an actor of bile duct mat-
uration during biliary morphogenesis. Our data suggest that a mutual cross-talk between LKB1
and the Notch pathway is involved in bile duct morphogenesis.
Supporting Information
S1 Table. List of primer sequences.
(DOCX)
S2 Table. List of 253 non-redundant genes differentially expressed in KO vs WT LKB1
mice.  p< .001;  fold-change>1.5.
(XLSX)
S3 Table. List of 237 non-redundant genes differentially expressed in KO vs WT RBPJ
mice.  p< .001;  fold-change>1.5.
(XLSX)
S4 Table. List of 54 non-redundant genes differentially expressed in both LKB1 and RBPJ
KO vs WTmice.  p< .001;  fold-change>1.5.
(XLSX)
Acknowledgments
We are grateful to Béatrice Romagnolo Anne-Françoise Burnol and Pascale Bossard (Institut
Cochin, France), for their helpful discussions and to the animal facility of Institut Cochin for
maintenance of mouse colonies.
Notch signaling in the developing liver. RT-qPCR of different Notch positive target genes (Hey1, Heyl, Hes1 andNrarp) in 8- and 14-day old control and
mutant LKBKOlivemb mice. N = 3–4 per group. Error bars: SEM. F: Notch negatively regulates LKB1 level measured by western blot analysis and the
phosphorylation level of AMPK (pAMPK-T172). Statistical significance was evaluated using a two-sample unpaired Student’s t-test between KO andWT. *
P< 0.05. ** P<0.01.
doi:10.1371/journal.pone.0145400.g005
LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis
PLOS ONE | DOI:10.1371/journal.pone.0145400 December 21, 2015 13 / 16
Author Contributions
Conceived and designed the experiments: CP PAJ FL. Performed the experiments: PAJ AP S.
Charawi MT TD RD VD FD S. Colnot BT CC FL CP. Analyzed the data: PAJ AP CC FL CP.
Contributed reagents/materials/analysis tools: FD HG BT. Wrote the paper: PAJ HG CC FL
CP.
References
1. Jungermann K, Kietzmann T (1996) Zonation of parenchymal and nonparenchymal metabolism in liver.
Annu Rev Nutr 16: 179–203. PMID: 8839925
2. Lemaigre F, Zaret KS (2004) Liver development update: new embryo models, cell lineage control, and
morphogenesis. Curr Opin Genet Dev 14: 582–590. PMID: 15380251
3. Raynaud P, Carpentier R, Antoniou A, Lemaigre FP (2011) Biliary differentiation and bile duct morpho-
genesis in development and disease. Int J Biochem Cell Biol 43: 245–256. doi: 10.1016/j.biocel.2009.
07.020 PMID: 19735739
4. Takashima Y, Terada M, Kawabata M, Suzuki A (2015) Dynamic three-dimensional morphogenesis of
intrahepatic bile ducts in mouse liver development. Hepatology 61: 1003–1011. doi: 10.1002/hep.
27436 PMID: 25212491
5. Geisler F, Strazzabosco M (2015) Emerging roles of Notch signaling in liver disease. Hepatology 61:
382–392. doi: 10.1002/hep.27268 PMID: 24930574
6. Emerick KM, Rand EB, Goldmuntz E, Krantz ID, Spinner NB, et al. (1999) Features of Alagille syn-
drome in 92 patients: frequency and relation to prognosis. Hepatology 29: 822–829. PMID: 10051485
7. Li L, Krantz ID, Deng Y, Genin A, Banta AB, et al. (1997) Alagille syndrome is caused by mutations in
human Jagged1, which encodes a ligand for Notch1. Nat Genet 16: 243–251. PMID: 9207788
8. McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, et al. (2006) NOTCH2mutations cause
Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J HumGenet 79:
169–173. PMID: 16773578
9. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, et al. (1997) Mutations in the human Jagged1
gene are responsible for Alagille syndrome. Nat Genet 16: 235–242. PMID: 9207787
10. McCright B, Lozier J, Gridley T (2002) A mouse model of Alagille syndrome: Notch2 as a genetic modi-
fier of Jag1 haploinsufficiency. Development 129: 1075–1082. PMID: 11861489
11. Kodama Y, Hijikata M, Kageyama R, Shimotohno K, Chiba T (2004) The role of notch signaling in the
development of intrahepatic bile ducts. Gastroenterology 127: 1775–1786. PMID: 15578515
12. Loomes KM, Russo P, Ryan M, Nelson A, Underkoffler L, et al. (2007) Bile duct proliferation in liver-
specific Jag1 conditional knockout mice: effects of gene dosage. Hepatology 45: 323–330. PMID:
17366661
13. Lozier J, McCright B, Gridley T (2008) Notch signaling regulates bile duct morphogenesis in mice.
PLoS One 3: e1851. doi: 10.1371/journal.pone.0001851 PMID: 18365007
14. Geisler F, Nagl F, Mazur PK, Lee M, Zimber-Strobl U, et al. (2008) Liver-specific inactivation of Notch2,
but not Notch1, compromises intrahepatic bile duct development in mice. Hepatology 48: 607–616.
doi: 10.1002/hep.22381 PMID: 18666240
15. Zong Y, Panikkar A, Xu J, Antoniou A, Raynaud P, et al. (2009) Notch signaling controls liver develop-
ment by regulating biliary differentiation. Development 136: 1727–1739. doi: 10.1242/dev.029140
PMID: 19369401
16. Sparks EE, Huppert KA, Brown MA, Washington MK, Huppert SS (2010) Notch signaling regulates for-
mation of the three-dimensional architecture of intrahepatic bile ducts in mice. Hepatology 51: 1391–
1400. doi: 10.1002/hep.23431 PMID: 20069650
17. Hofmann JJ, Zovein AC, Koh H, Radtke F, Weinmaster G, et al. (2010) Jagged1 in the portal vein mes-
enchyme regulates intrahepatic bile duct development: insights into Alagille syndrome. Development
137: 4061–4072. doi: 10.1242/dev.052118 PMID: 21062863
18. Alessi DR, Sakamoto K, Bayascas JR (2006) LKB1-dependent signaling pathways. Annu Rev Biochem
75: 137–163. PMID: 16756488
19. Jansen M, Ten Klooster JP, Offerhaus GJ, Clevers H (2009) LKB1 and AMPK family signaling: the inti-
mate link between cell polarity and energy metabolism. Physiol Rev 89: 777–798. doi: 10.1152/
physrev.00026.2008 PMID: 19584313
20. Shackelford DB, Shaw RJ (2009) The LKB1-AMPK pathway: metabolism and growth control in tumour
suppression. Nat Rev Cancer 9: 563–575. doi: 10.1038/nrc2676 PMID: 19629071
LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis
PLOS ONE | DOI:10.1371/journal.pone.0145400 December 21, 2015 14 / 16
21. Lizcano JM, Goransson O, Toth R, Deak M, Morrice NA, et al. (2004) LKB1 is a master kinase that acti-
vates 13 kinases of the AMPK subfamily, including MARK/PAR-1. Embo J 23: 833–843. PMID:
14976552
22. Baas AF, Kuipers J, van der Wel NN, Batlle E, Koerten HK, et al. (2004) Complete polarization of single
intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 116: 457–466. PMID: 15016379
23. Mirouse V, Billaud M The LKB1/AMPK polarity pathway. FEBS Lett 585: 981–985. doi: 10.1016/j.
febslet.2010.12.025 PMID: 21185289
24. Lo B, Strasser G, Sagolla M, Austin CD, Junttila M, et al. (2012) Lkb1 regulates organogenesis and
early oncogenesis along AMPK-dependent and -independent pathways. J Cell Biol 199: 1117–1130.
doi: 10.1083/jcb.201208080 PMID: 23266956
25. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, et al. (2005) The kinase LKB1 mediates glu-
cose homeostasis in liver and therapeutic effects of metformin. Science 310: 1642–1646. PMID:
16308421
26. Patel K, Foretz M, Marion A, Campbell DG, Gourlay R, et al. (2014) The LKB1-salt-inducible kinase
pathway functions as a key gluconeogenic suppressor in the liver. Nat Commun 5: 4535. doi: 10.1038/
ncomms5535 PMID: 25088745
27. Fu D, Wakabayashi Y, Ido Y, Lippincott-Schwartz J, Arias IM (2010) Regulation of bile canalicular net-
work formation and maintenance by AMP-activated protein kinase and LKB1. J Cell Sci 123: 3294–
3302. doi: 10.1242/jcs.068098 PMID: 20826460
28. Woods A, Heslegrave AJ, Muckett PJ, Levene AP, Clements M, et al. (2011) LKB1 is required for
hepatic bile acid transport and canalicular membrane integrity in mice. Biochem J 434: 49–60. doi: 10.
1042/BJ20101721 PMID: 21118154
29. Bardeesy N, Sinha M, Hezel AF, Signoretti S, Hathaway NA, et al. (2002) Loss of the Lkb1 tumour sup-
pressor provokes intestinal polyposis but resistance to transformation. Nature 419: 162–167. PMID:
12226664
30. Kellendonk C, Opherk C, Anlag K, Schutz G, Tronche F (2000) Hepatocyte-specific expression of Cre
recombinase. Genesis 26: 151–153. PMID: 10686615
31. Han H, Tanigaki K, Yamamoto N, Kuroda K, Yoshimoto M, et al. (2002) Inducible gene knockout of tran-
scription factor recombination signal binding protein-J reveals its essential role in T versus B lineage
decision. Int Immunol 14: 637–645. PMID: 12039915
32. Coulouarn C, Cavard C, Rubbia-Brandt L, Audebourg A, Dumont F, et al. (2012) Combined hepatocel-
lular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFbeta signaling
pathways. Carcinogenesis 33: 1791–1796. doi: 10.1093/carcin/bgs208 PMID: 22696594
33. Coulouarn C, Gomez-Quiroz LE, Lee JS, Kaposi-Novak P, Conner EA, et al. (2006) Oncogene-specific
gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarci-
nogenesis. Hepatology 44: 1003–1011. PMID: 17006931
34. Knuth A, Gabbert H, DippoldW, Klein O, SachsseW, et al. (1985) Biliary adenocarcinoma. Characteri-
sation of three new human tumor cell lines. J Hepatol 1: 579–596. PMID: 4056357
35. Sakamoto K, Zarrinpashneh E, Budas GR, Pouleur AC, Dutta A, et al. (2006) Deficiency of LKB1 in
heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1. Am J Physiol Endo-
crinol Metab 290: E780–788. PMID: 16332922
36. Xiao SY, Wang HL, Hart J, Fleming D, Beard MR (2001) cDNA arrays and immunohistochemistry iden-
tification of CD10/CALLA expression in hepatocellular carcinoma. Am J Pathol 159: 1415–1421.
PMID: 11583969
37. Antoniou A, Raynaud P, Cordi S, Zong Y, Tronche F, et al. (2009) Intrahepatic bile ducts develop
according to a newmode of tubulogenesis regulated by the transcription factor SOX9. Gastroenterol-
ogy 136: 2325–2333. doi: 10.1053/j.gastro.2009.02.051 PMID: 19403103
38. Carpentier R, Suner RE, van Hul N, Kopp JL, Beaudry JB, et al. (2011) Embryonic ductal plate cells
give rise to cholangiocytes, periportal hepatocytes, and adult liver progenitor cells. Gastroenterology
141: 1432–1438, 1438 e1431–1434. doi: 10.1053/j.gastro.2011.06.049 PMID: 21708104
39. Coffinier C, Gresh L, Fiette L, Tronche F, Schutz G, et al. (2002) Bile systemmorphogenesis defects
and liver dysfunction upon targeted deletion of HNF1beta. Development 129: 1829–1838. PMID:
11934849
40. Clotman F, Lannoy VJ, Reber M, Cereghini S, Cassiman D, et al. (2002) The onecut transcription factor
HNF6 is required for normal development of the biliary tract. Development 129: 1819–1828. PMID:
11934848
41. Raynaud P, Tate J, Callens C, Cordi S, Vandersmissen P, et al. (2011) A classification of ductal plate
malformations based on distinct pathogenic mechanisms of biliary dysmorphogenesis. Hepatology 53:
1959–1966. doi: 10.1002/hep.24292 PMID: 21391226
LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis
PLOS ONE | DOI:10.1371/journal.pone.0145400 December 21, 2015 15 / 16
42. Lahmar M, Catelain C, Poirault S, Dorsch M, Villeval JL, et al. (2008) Distinct effects of the soluble ver-
sus membrane-bound forms of the notch ligand delta-4 on human CD34+CD38low cell expansion and
differentiation. Stem Cells 26: 621–629. PMID: 18055448
43. Sebbagh M, Santoni MJ, Hall B, Borg JP, Schwartz MA (2009) Regulation of LKB1/STRAD localization
and function by E-cadherin. Curr Biol 19: 37–42. doi: 10.1016/j.cub.2008.11.033 PMID: 19110428
44. Noah TK, Shroyer NF (2013) Notch in the intestine: regulation of homeostasis and pathogenesis. Annu
Rev Physiol 75: 263–288. doi: 10.1146/annurev-physiol-030212-183741 PMID: 23190077
45. Shorning BY, Zabkiewicz J, McCarthy A, Pearson HB, Winton DJ, et al. (2009) Lkb1 deficiency alters
goblet and paneth cell differentiation in the small intestine. PLoS One 4: e4264. doi: 10.1371/journal.
pone.0004264 PMID: 19165340
46. Pajvani UB, Shawber CJ, Samuel VT, Birkenfeld AL, Shulman GI, et al. (2011) Inhibition of Notch sig-
naling ameliorates insulin resistance in a FoxO1-dependent manner. Nat Med 17: 961–967. doi: 10.
1038/nm.2378 PMID: 21804540
47. Pajvani UB, Qiang L, Kangsamaksin T, Kitajewski J, Ginsberg HN, et al. (2013) Inhibition of Notch
uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Nat Med 19:
1054–1060. doi: 10.1038/nm.3259 PMID: 23832089
LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis
PLOS ONE | DOI:10.1371/journal.pone.0145400 December 21, 2015 16 / 16
